The Role of Genotyping in Diagnosing Cardiac Channelopathies
Authors:
- G Michael VincentGVG Michael Vincent
- Li ZhangLZLi Zhang
- 1 January 2005
- journal article
- review article
- Published by Springer Nature in Molecular Diagnosis
- Vol. 9 (3) , 105-118
Abstract
The role of genotyping for diagnosis of the cardiac ion channelopathies is a work in progress. No formal guidelines or other publications discussing current recommendations for genotyping exist, particularly for clinical/commercial genotyping. Further, the field is changing rapidly, opinions vary and, additionally, circumstances inside the US are different from outside. The following considerations are a current summary based on a review of the literature, discussions with experts in the field, and our own opinions and also include a brief discussion about genotyping for therapeutic decision making. Research-based genotyping is very important for continued understanding of the details of pathophysiology and the complex regulatory processes in these diseases. Clinical/commercial genotyping for diagnosis is important for identifying patients with reduced penetrance of the phenotype since effective therapies to prevent sudden death exist. Clinical genotyping for therapeutic advantage has limited application at present but will become much more important if and when genotype-/mutation-type specific therapies are shown to be effective. The recommendations will progressively change as new research findings and new genotyping technologies appear.Keywords
This publication has 100 references indexed in Scilit:
- Flecainide and propafenone induced ST-segment elevation in patients with atrial fibrillation: Clue to specificity of Brugada-type electrocardiographic changesThe American Journal of Cardiology, 2004
- An intronic mutation causes long QT syndromeJACC, 2004
- Sudden death in patients without structural heart diseaseJACC, 2004
- LONG QT SYNDROMECardiology Clinics, 2000
- Use of Implantable Cardioverter-Defibrillators in the Congenital Long QT SyndromeThe American Journal of Cardiology, 1996
- Long QT syndrome associated with syndactyly identified in femalesThe American Journal of Cardiology, 1995
- Implantierbarer Defibrillator bei QT-SyndromDMW - Deutsche Medizinische Wochenschrift, 1995
- Implantable cardioverter defibrillator therapy in patients with arrhythmogenic right ventricular cardiomyopathy, long QT syndrome, or no structural heart diseaseAmerican Heart Journal, 1994
- The Spectrum of Symptoms and QT Intervals in Carriers of the Gene for the Long-QT SyndromeNew England Journal of Medicine, 1992
- Congenital deaf-mutism, functional heart disease with prolongation of the Q-T interval, and sudden deathAmerican Heart Journal, 1957